Benefits

The Biosimilars & Biologics Summit 2023 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest in biosimilars therapeutics, which can be interchangeable with biologics to reduce healthcare costs and chronic disease management.

 

Benefits of attending include:

 

• Two days of in-depth presentations revealing the latest market intelligence addressing the diagnostic industry’s collective focus by sharing results and industry experiences.
• Exclusive networking opportunity, a chance to engage with other professionals with shared challenges and experiences in this fast-developing sector.
• Updates on regional projects and research led by leading biosimilars technology experts detailing their experiences, findings, and new proposals.
• Technical presentations from biosimilars developers showcasing the latest results from recent tests and trials, technological developments, and new technical know-how.
• New case studies on specific examples from leading industry experts in diagnostic development.
• Unique opportunity to integrate with a multitude of manufacturers and seek new market opportunities by demonstrating an insight into this evolving industry.

 

Attending this conference will enable you to:

• Understand the current market dynamics of the biotech, pharma, and biopharma industries
• Learn how to develop strategies for biosimilars design and development for chronic disease management
• Hear the latest trends with an overview of the year and projections for the biotech and pharmaceutical industries
• Discuss innovations and technological developments of biosimilars as novel drug modalities for chronic disease management
• Access different ideas and perspectives from a multitude of experts and allied industries combining regional experiences

 

Who should attend?

This event aims at leading biotech, biopharma, pharmaceutical companies, and government and policy think tanks seeking to learn more about developing biosimilars that can improve access to therapeutic interventions and reduce healthcare costs. Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, Managers, and Stakeholders involved in:

 

Biosimilars Research	Biosimilars Delivery Platforms	Clinical Trials and Approvals
Biosimilars Drug Development	Biological Engineering of Biologics	Immunization Research & Development
Biosimilars Manufacturing	Bioinformatics	Manufacturing Research & Innovation
Biologics Technologies	Cell Lines Development	Research and Development
Genetic Engineering	Clinical Research and Development	Strategy, Projects, & Public Affairs
Biotechnology Research	Cost Reduction Strategies	Legal and Compliance Work
Modalities Research	Sales and Marketing Initiatives	Equipment Certification Services
Translational Research	Business Development	News Reporting and Journalism

 

From the following industries and companies:

Biotechnology Companies	Biosimilars Companies	Associations and Alliances
Pharmaceutical Companies	Generic Drugs Companies	Universities and Academia
Biosimilars Industries	Medical Technology Companies	Research and Development
Biologics Industries	Cosmetic Companies	Government Agencies
Drug Development Companies	Clinical Research Organisations	Consultants and Advisors
Drug Discovery Companies	Biological Engineering Companies	Public Consultation Groups
Formulation Companies	Global Healthcare Institutions	Legal and Compliance Services
Public Healthcare Providers	International Quality Standards	News Reporters and Journalists

 

Book now
To secure your place at The Biosimilars & Biologics Summit 2023 or if you require more information, please contact delegates@iQ-Hub.com